SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 231 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,468,596 | -38.1% | 1,657,557 | +9.7% | 0.00% | -33.3% |
| Q3 2022 | $2,372,000 | -11.6% | 1,510,781 | +13.2% | 0.01% | -14.3% |
| Q2 2022 | $2,683,000 | -36.5% | 1,335,071 | -26.3% | 0.01% | +75.0% |
| Q1 2022 | $4,222,000 | -14.0% | 1,811,694 | +71.7% | 0.00% | -63.6% |
| Q4 2021 | $4,907,000 | -18.3% | 1,055,243 | +34.1% | 0.01% | -26.7% |
| Q3 2021 | $6,005,000 | -2.0% | 786,986 | +24.4% | 0.02% | -11.8% |
| Q2 2021 | $6,130,000 | +46.3% | 632,659 | +24.9% | 0.02% | +13.3% |
| Q1 2021 | $4,189,000 | +123.4% | 506,575 | +84.4% | 0.02% | +114.3% |
| Q4 2020 | $1,875,000 | +29.0% | 274,735 | +110.7% | 0.01% | 0.0% |
| Q3 2020 | $1,454,000 | +161.0% | 130,393 | +47.0% | 0.01% | +133.3% |
| Q2 2020 | $557,000 | +605.1% | 88,710 | +105.7% | 0.00% | +200.0% |
| Q1 2020 | $79,000 | -38.8% | 43,122 | +12.6% | 0.00% | 0.0% |
| Q4 2019 | $129,000 | +20.6% | 38,309 | -23.1% | 0.00% | 0.0% |
| Q3 2019 | $107,000 | +205.7% | 49,791 | +283.3% | 0.00% | – |
| Q2 2019 | $35,000 | – | 12,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
| B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
| EMFO, LLC | 209,398 | $185,527 | 0.19% |
| Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
| Mayo Clinic | 300,000 | $267,000 | 0.14% |
| swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
| Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
| Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
| EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
| Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |